Yahoo
MCE - Delayed Quote EUR

Clínica Baviera, S.A. (CBAV.MC)

53.00 -0.80 (-1.49%)
At close: October 30 at 5:35:14 PM GMT+1
Chart Range Bar
Loading chart for CBAV.MC
  • Previous Close 53.80
  • Open 53.60
  • Bid 12.80 x --
  • Ask 55.00 x --
  • Day's Range 53.00 - 54.00
  • 52 Week Range 40.10 - 62.00
  • Volume 1,298
  • Avg. Volume 1,755
  • Market Cap (intraday) 849.706M
  • Beta (5Y Monthly) 0.75
  • PE Ratio (TTM) 18.47
  • EPS (TTM) 2.87
  • Earnings Date (est.) --
  • Forward Dividend & Yield 1.57 (2.95%)
  • Ex-Dividend Date Jun 10, 2026
  • 1y Target Est --

Clínica Baviera, S.A., a medical company, provides ophthalmologic medicine services in Spain, Germany, and rest of Europe. The company offers refractive, presbyopia, and cataract surgeries; and oculoplastia, corneal disease, dry eye, strabismus, pediatric ophthalmology, glaucoma, neuro-ophthalmological, disorders, and blepharoplasty treatments. It also provides external and internal consultations, surgery treatments, and rehabilitation services. The company was formerly known as Clínica Oftalmológica Baviera, S.L. and changed its name to Clínica Baviera, S.A. in 2000. Clínica Baviera, S.A. was incorporated in 1992 and is based in Madrid, Spain. Clínica Baviera, S.A. is a subsidiary of Aier Eye International (Europe), S.L.U.

www.clinicabaviera.com

2,009

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is IBEX 35 (^IBEX) .

YTD Return

CBAV.MC
10.85%
IBEX 35 (^IBEX)
7.48%

1-Year Return

CBAV.MC
29.59%
IBEX 35 (^IBEX)
15.50%

3-Year Return

CBAV.MC
204.72%
IBEX 35 (^IBEX)
109.15%

5-Year Return

CBAV.MC
256.52%
IBEX 35 (^IBEX)
105.93%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY22
Revenue 53.74M
Earnings 5.35M
Profit Margin 9.96%

Q1

FY22

Q2

FY22

Q3

FY22

Q4

FY22

0
10M
20M
30M
40M
50M
10.0%
12.0%
14.0%
16.0%
18.0%
20.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    14.33%

  • Return on Assets (ttm)

    16.92%

  • Return on Equity (ttm)

    45.93%

  • Revenue (ttm)

    320.67M

  • Net Income Avi to Common (ttm)

    45.95M

  • Diluted EPS (ttm)

    2.87

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    51.59M

  • Total Debt/Equity (mrq)

    63.65%

  • Levered Free Cash Flow (ttm)

    42.44M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: